SCHEMBL15076391

SCHEMBL15076391

CS(=O)(=O)c1cc(C(=O)Nc2cc(F)c(F)c(F)c2)c(F)cc1F

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.55
▸ ENPP2 Q13822 7/20 0.49
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ LPAR1 Q92633 3/20 0.46
▸ BCAT2 O15382 1/20 0.43
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA9 Q16790 2/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ AKR1C3 P42330 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ GPR27 Q9NS67 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21624591 0.85 CYP1A2 (0.52) CYP1A2ENPP2CYP3A4CYP2D6CYP2C9
SCHEMBL21623377 0.80 CYP1A2 (0.47) CYP1A2ENPP2CYP3A4CYP2D6CYP2C9
SCHEMBL16768721 0.79 CYP1A2 (0.47) CYP1A2ENPP2CYP3A4CYP2D6CYP2C9
SCHEMBL15076612 0.79 CYP1A2 (0.46) CYP1A2ENPP2CYP3A4CYP2D6CYP2C9
SCHEMBL15076378 0.78 MAPT (0.51) CYP1A2TP53
SCHEMBL15836202 0.77 PTGS2 (0.37) BCAT2
SCHEMBL15076729 0.77 CYP3A4 (0.65) CYP1A2ENPP2CYP3A4CYP2D6CYP2C9
SCHEMBL15076785 0.77 TP53 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL21623230 0.76 CYP1A2 (0.65) CYP1A2ENPP2CYP3A4CYP2D6CYP2C9
SCHEMBL19157933 0.76 CCR2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013096744-A1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS, INC. (US) 2013-06-27 — — WO disclosed
Send feedback